HDL action on the vascular wall: is the answer NO?

AUTOR(ES)
FONTE

American Society for Clinical Investigation

RESUMO

Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

Documentos Relacionados